New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
06:50 EDTBIO, BIOBio-Rad upgraded to Outperform from Underperform at CLSA
CLSA upgraded Bio-Rad based on earnings leverage, consistent diagnostics growth, ERP completion, easier currency comps, and exposure to Asia. Price target raised to $124 form $103
News For BIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 18, 2014
16:18 EDTBIOBio-Rad receives FDA premarket application approval for Geenius HIV 1/2 test
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use